mRNA COVID-19 vaccine
Showing 1 - 25 of >10,000
SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)
Not yet recruiting
- SARS-CoV2 Infection
- Coronavirus Infection
- mRNA- COVID-19
- Prevnar13
-
Hamilton, Ontario, CanadaMcMaster University
Jun 29, 2022
Fever After Vaccination, Fever, Seizures Fever Trial in United States (Pfizer-BioNTech COVID-19 Vaccine, Routine Childhood
Not yet recruiting
- Fever After Vaccination
- +2 more
- Pfizer-BioNTech COVID-19 Vaccine
- Routine Childhood Vaccinations
-
Oakland, California
- +4 more
Sep 8, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)
Recruiting
- COVID-19
- Corona Virus Infection
- Pfizer-BioNTech mRNA COVID-19 vaccine
- Moderna mRNA COVID-19 vaccine
-
Ann Arbor, MichiganUniversity of Michigan
Apr 23, 2022
Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine
Recruiting
- Influenza, Human
- COVID-19
- Comirnaty
- Quadrivalent Influenza Vaccine
-
New York, New YorkPfizer
May 11, 2023
BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil
Not yet recruiting
- COVID-19
- Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
- CoronaVac COVID-19 vaccine
-
Toledo, Paraná, BrazilUnidade de Pronto Atendimento (UPA) de Toledo
May 27, 2022
Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic
Not yet recruiting
- Chronic Lymphocytic Leukemia
- COVID-19 Infection
- Biospecimen Collection
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
COVID-19, SARS-CoV-2 Infection Trial (SCTV01E-2, SCTV01E)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01E-2
- SCTV01E
- (no location specified)
Jul 4, 2023
Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID
Not yet recruiting
- Influenza
- +3 more
- Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
- +2 more
-
Phoenix, Arizona
- +7 more
Aug 30, 2023
COVID-19, SARS-CoV-2 Infection Trial in Morelia (Recombinant COVID-19 variant Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- Recombinant COVID-19 variant Vaccine (Sf9 Cell)
- +3 more
-
Morelia, Michoacán De Ocampo, MexicoClínica de Enfermedades Crónicas y de Procedimientos Especiales,
Jul 18, 2022
SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10
Recruiting
- SARS-CoV-2 Infection
- Placebo
- +4 more
-
Hangzhou, Zhejiang, ChinaShulan (Hangzhou) Hospital
Nov 7, 2023
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),
Not yet recruiting
- COVID-19
- +4 more
- Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
- Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
- (no location specified)
Sep 29, 2023
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
Vaccination; Infection, COVID-19 Trial (Comirnaty)
Not yet recruiting
- Vaccination; Infection
- COVID-19
- Comirnaty
- (no location specified)
Aug 4, 2023
Immunogenicity of BNT162b2 Covid-19 Vaccine in Elderly People
Completed
- Immunogenicity, Vaccine
-
Thessaloníki, Thessaloniki, GreeceG. Gennimatas General Hospital
Aug 3, 2022
Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)
Active, not recruiting
- Chronic Kidney Diseases
- COVID-19
- Pfizer-BioNTech COVID-19 Vaccine
- MODERNA SARS-CoV-2 Vaccine
-
Scarborough, Ontario, Canada
- +2 more
Aug 5, 2022
BNT162b2 mRNA Covid-19 Vaccine in Brazil
Recruiting
- Covid19
- Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
- +3 more
-
Toledo, Paraná, BrazilPronto Atendimento Municipal de Toledo
Dec 14, 2021
COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, mRNA-1273)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01E
- mRNA-1273
- (no location specified)
Apr 25, 2022
COVID-19, Sars-CoV-2 Infection Trial (SCTV01E, Comirnaty)
Not yet recruiting
- COVID-19
- Sars-CoV-2 Infection
- SCTV01E
- Comirnaty
- (no location specified)
Feb 14, 2022
Vaccination; Infection, COVID-19 Trial in Leiden (solid microneedle skin patch, mRNA-1273, standard needle)
Recruiting
- Vaccination; Infection
- COVID-19
- solid microneedle skin patch
- +2 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 14, 2022
SARS-CoV-2 Infection Trial in Groningen, Utrecht, Auckland (VLA2001)
Active, not recruiting
- SARS-CoV-2 Infection
- VLA2001
-
Groningen, Netherlands
- +3 more
Jan 17, 2023
Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta
Not yet recruiting
- Vaccine Reaction
- COVID-19
- Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
- VidPrevtyn® Beta vaccine (Sanofi/GSK)
-
Paris, FranceCIC 1417 Cochin-Pasteur
Feb 28, 2023
Relapsing Multiple Sclerosis (RMS) Trial in United States (Ofatumumab, mRNA COVID-19 vaccine, interferon or glatiramer acetate)
Recruiting
- Relapsing Multiple Sclerosis (RMS)
- Ofatumumab
- +2 more
-
Phoenix, Arizona
- +3 more
Jul 20, 2022
COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)
Not yet recruiting
- COVID-19
- mRNA-CR-04 vaccine 10μg
- +3 more
-
San Diego, California
- +3 more
Aug 1, 2023